Genetic Testing: A Lifesaving Tool for Critically Ill Adults

Genomic testing, which sequences an individual's entire genome or gene set, is now a viable diagnostic tool due to its increased affordability and accessibility. Notably, its application in infants and children with suspected genetic disorders or complex medical histories has demonstrated significant healthcare cost savings and improved health outcomes (1^✔ ✔Trusted Source
Genetic association studies in critically ill patients: a systematic review

Go to source).

The Gap in Genetic Diagnosis: Adults and Genomic Testing

 Despite well-documented benefits in the pediatric population, genomic testing is not commonly used in adults, largely because it is believed that the likelihood of finding undiagnosed genetic conditions decreases with age. Now, a team of researchers led by Theodore G. Drivas of the Perelman School of Medicine has challenged this idea, finding previously unknown genetic diagnoses in a large percent of adults admitted to intensive care units (ICUs) at Penn. The findings are published in The American Journal of Human Genetics.

 Our study shows that genetic disorders are a surprisingly common reason people end up in the intensive care unit—even in adults,” says Drivas. “Genetic disease does not only affect pediatric patients and young adults but appears to be important—and underdiagnosed—across the life span.”

 The researchers retrospectively analyzed whole exome sequencing (WES) data—which captures the protein-coding regions of DNA known as exons—from 365 adults aged 18 to 40 years who had been admitted to an ICU in the University of Pennsylvania Health System. Two physicians board certified in both medical genetics and internal medicine reviewed each WES report and patient chart.

According to Drivas, they found that nearly one in four patients in this study had a genetic condition related to their ICU admission, which was unknown to nearly half of those patients and their doctors. Additionally, for over 75% of these patients, these diagnoses call for specific management guidelines.

Genetic testing and counseling centers in India
Genetic testing involves the study of genetic material, using laboratory techniques, to detect a genetic condition in an individual. Here are some genetic testing and counseling centers in India.

 “Importantly, we found no correlation between patient age and the likelihood of having a genetic diagnosis,” says Drivas. “This means that older adults were just as likely as younger adults to have a genetic diagnosis causing their critical illness, which is contrary to what many assumed would be true.”

 The study also found “striking” race-based disparities in access to genetic testing. “Black patients are significantly less likely to have known/documented diagnoses,” write the authors, noting that while diagnoses were documented for 63.1% of white patients and 100% of Asian patients, they were only documented for 27.7% of Black patients.

Quiz on Genetic Disorders
genetic mutations and these mutations may be small, affecting just one gene or affecting entire chromosomes. Such mutations may develop spontaneously or they may be inherited from either parent. The consequences of such genetic disorders can vary ...



Enhancing Patient Care through Exome/Genome Sequencing

 “This disparity cannot be explained by demographic differences or differences in overall diagnostic rate of exome sequencing between these different groups,” write the authors. “It is likely that these disparities reflect biases in physician referral practices for patients of different backgrounds and societal barriers, including long wait times and limited hours for genetics clinic evaluation.”

 Drivas notes, “In addition to diagnosing genetic diseases, when we also consider the added benefit of exome/genome sequencing in providing care teams with valuable pharmacogenomic information that can help direct medication dosing to ensure efficacy and prevent adverse events, our data suggest that the majority of critically ill patients could benefit from such testing. However, such testing is only very rarely performed in critically ill adults.”

Emerging Role of Genetic Testing in Diagnosis of Early-Life Epilepsies
DNA sequencing yields more data for determining etiology and diagnosis of early life epilepsies.

 But Drivas and his colleagues have a solution. They recommend offering genetic testing to all adults admitted to the ICU.

 “Genetic testing costs little compared to an ICU stay, yet it’s rarely offered to adults”, says Drivas. “Our findings strongly suggest that we should consider offering broad genetic testing to patients as part of their ICU admission; knowing a patient’s genetic diagnosis can mean better care, better survival, and fewer health disparities.”

 Currently, Drivas and his team are collaborating with the MyPennGenome project, led by Bogdan Pasaniuc of Penn Medicine, to help with this goal.

 “We are hoping to prospectively sequence the genomes of ICU-admitted Penn patients and return these results to the patients and their treatment teams as part of a pilot study,” adds Drivas. “Our hope is that as the utility of broad genetic testing in the critically ill adult patient population continues to be proven through studies like these, the health system will adopt it as part of routine patient care.

 Know the Code, Save a Life
Reference:

1. Genetic association studies in critically ill patients: a systematic review - (https://pubmed.ncbi.nlm.nih.gov/40168842/)

Source-Medindia